UA89349C2 - Таблетка без покриття, яка містить оланзапін, та спосіб її одержання - Google Patents

Таблетка без покриття, яка містить оланзапін, та спосіб її одержання

Info

Publication number
UA89349C2
UA89349C2 UAA200504641A UAA200504641A UA89349C2 UA 89349 C2 UA89349 C2 UA 89349C2 UA A200504641 A UAA200504641 A UA A200504641A UA A200504641 A UAA200504641 A UA A200504641A UA 89349 C2 UA89349 C2 UA 89349C2
Authority
UA
Ukraine
Prior art keywords
preparing
tablet containing
uncoated tablet
containing olanzapine
olanzapine
Prior art date
Application number
UAA200504641A
Other languages
English (en)
Russian (ru)
Inventor
Станка Перч
Іванка Банко
Іванка Коленч
Original Assignee
Крка Товарна Здравіл, Д.Д., Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32173824&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA89349(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Крка Товарна Здравіл, Д.Д., Ново Место filed Critical Крка Товарна Здравіл, Д.Д., Ново Место
Publication of UA89349C2 publication Critical patent/UA89349C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Винахід належить до галузі фармацевтики і стосується таблетки без покриття, яка одержана прямим пресуванням гомогенної суміші, що містить (а) оланзапін або його фармацевтичнo прийнятну сіль, (b) моносахарид і/або олігосахарид, (с) полісахарид і, необов'язково, один чи кілька додаткових наповнювачів, за відсутності будь-якого розчинника. Винахід також стосується способу одержання такої таблетки.
UAA200504641A 2002-10-18 2003-10-16 Таблетка без покриття, яка містить оланзапін, та спосіб її одержання UA89349C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200200255A SI21303A (sl) 2002-10-18 2002-10-18 Farmacevtska formulacija olanzapina
PCT/SI2003/000036 WO2004035027A1 (en) 2002-10-18 2003-10-16 Pharmaceutical formulation of olanzapine

Publications (1)

Publication Number Publication Date
UA89349C2 true UA89349C2 (uk) 2010-01-25

Family

ID=32173824

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200504641A UA89349C2 (uk) 2002-10-18 2003-10-16 Таблетка без покриття, яка містить оланзапін, та спосіб її одержання

Country Status (18)

Country Link
US (2) US20050288276A1 (uk)
EP (1) EP1558219B1 (uk)
AT (1) ATE374600T1 (uk)
AU (1) AU2003269792A1 (uk)
CA (1) CA2502582C (uk)
CY (1) CY1107819T1 (uk)
DE (1) DE60316714T2 (uk)
DK (1) DK1558219T3 (uk)
EA (1) EA008516B1 (uk)
ES (1) ES2295626T3 (uk)
HR (1) HRP20050342B1 (uk)
NO (1) NO20052408L (uk)
PL (1) PL206217B1 (uk)
PT (1) PT1558219E (uk)
RS (1) RS51488B (uk)
SI (2) SI21303A (uk)
UA (1) UA89349C2 (uk)
WO (1) WO2004035027A1 (uk)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006018318A1 (en) * 2004-08-18 2006-02-23 Synthon B.V. Liquid paroxetine compositions
CZ297214B6 (cs) * 2005-02-02 2006-10-11 Zentiva, A. S. Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
GB0522473D0 (en) * 2005-11-03 2005-12-14 Actavis Group A pharmaceutical formulation
GB0522474D0 (en) * 2005-11-03 2005-12-14 Actavis Group A pharmaceutical formulation
ES2279715B1 (es) 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
US20070293479A1 (en) * 2006-05-18 2007-12-20 Osinga Niels J Olanzapine pharmaceutical composition
AR063043A1 (es) * 2006-09-29 2008-12-23 Synthon Bv Composicion farmaceutica de olanzapina
WO2012014012A1 (es) * 2010-07-27 2012-02-02 Laboratorios Andrómaco S.A. Procedimiento para preparar comprimidos de disolucion rapida oral que comprenden la forma i de olanzapina, los comprimidos obtenidos y su uso para el tratamiento de la esquizofrenia.
WO2012153347A2 (en) 2011-05-04 2012-11-15 Zentiva K.S. Oral pharmaceutical composition of olanzapine form 1
WO2013066280A1 (en) * 2011-10-31 2013-05-10 Mahmut Bilgic Water soluble antipsychotic formulations
CN103919782B (zh) * 2013-01-15 2016-12-28 天津药物研究院有限公司 一种含有奥氮平的药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2115116C3 (de) * 1970-03-27 1982-04-15 Sankyo Co., Ltd., Tokyo Gleitmittel und Verfahren zu dessen Herstellung
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
HUP9904065A3 (en) * 1996-09-24 2001-10-29 Lilly Co Eli Coated particle formulations containing olanzapine
US6348458B1 (en) * 1999-12-28 2002-02-19 U & I Pharmaceuticals Ltd. Polymorphic forms of olanzapine
EP2108651A1 (en) * 2001-12-24 2009-10-14 Sun Pharmaceuticals Industries Ltd. Crystalline form I of 2-methyl-4-(4-methyl-1-piperazinyl) 10H thieno[2,3-B][1,5] benzodiazepine
WO2003086361A1 (en) * 2002-04-18 2003-10-23 Dr. Reddy's Laboratories Ltd. Rapidly dispersing solid oral compositions

Also Published As

Publication number Publication date
DE60316714D1 (de) 2007-11-15
PL376413A1 (en) 2005-12-27
NO20052408D0 (no) 2005-05-13
EA008516B1 (ru) 2007-06-29
ATE374600T1 (de) 2007-10-15
SI1558219T1 (sl) 2008-02-29
US20050288276A1 (en) 2005-12-29
WO2004035027A1 (en) 2004-04-29
AU2003269792A1 (en) 2004-05-04
EA200500671A1 (ru) 2005-10-27
CY1107819T1 (el) 2013-06-19
PL206217B1 (pl) 2010-07-30
HRP20050342A2 (hr) 2006-04-30
DK1558219T3 (da) 2007-10-29
ES2295626T3 (es) 2008-04-16
CA2502582C (en) 2010-08-03
US20110319395A1 (en) 2011-12-29
RS51488B (en) 2011-04-30
CA2502582A1 (en) 2004-04-29
PT1558219E (pt) 2008-01-04
NO20052408L (no) 2005-07-04
EP1558219B1 (en) 2007-10-03
RS20050292A (en) 2007-08-03
HRP20050342B1 (hr) 2013-11-08
EP1558219A1 (en) 2005-08-03
SI21303A (sl) 2004-04-30
DE60316714T2 (de) 2008-07-17

Similar Documents

Publication Publication Date Title
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
AP1760A (en) Platinum derivative pharmaceutical formulations.
WO2001027109A3 (de) Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridin-3-yl)-amin-derivate
HK1067626A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
WO2006053089A3 (en) Methods and formulations for making pharmaceutical compositions containing bupropion
HUP0202233A3 (en) Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
MXPA04003346A (es) Formulacion de dosis oral de disolucion instantanea.
IL150528A0 (en) Ibuprofen containing active agent preparation
WO2005065639A3 (en) Novel pharmaceutical compositions
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
NO20055016L (no) Farmasoytisk sammensetning som fast doseringsform og fremgangsmate for fremstilling derav
HUP0402093A3 (en) 3-phenyl-2-phenethylthio-propionic acid derivatives as selective agonists of ppar-alpha, their preparation and pharmaceutical compositions containing them
GEP20043377B (en) Pharmaceutical Complex
DK1144420T3 (da) Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf
EP1634585A4 (en) MEDICINAL PRODUCTS CONTAINING DELAYED MICROTEIL, PROCESS FOR ITS PREPARATION AND MICROPARTICLE CONTAINING PREPARATION
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same
WO2000051603A3 (en) Compositions of remifentanil
WO2002041875A3 (de) Verfahren zur herstellung leicht löslicher arzneimittelformulierungen und entsprechende formulierungen
WO2007117314A3 (en) Bupropion controlled release formulations and methods of making
HU0100122D0 (en) Use of tiludronic acid and derivatives thereof in poultry for preparation of a medicinal product for preventing and treating osteoporosis
UA39339A (uk) Спосіб отримання гіполіпідемічного засобу в таблетках
TW200621314A (en) Methods and formulations for making pharmaceutical compositions containing bupropion
HUP9902592A3 (en) Isoquinoline derivatives, pharmaceutical compositions containing such active ingredients and process for producing them